EP0000649A1 - 5-substituted-1,2-dihydro-3H-pyrrolo(1,2-a)pyrrole-1-carbonitriles and process for their conversion to the corresponding 1-carboxylic acids - Google Patents

5-substituted-1,2-dihydro-3H-pyrrolo(1,2-a)pyrrole-1-carbonitriles and process for their conversion to the corresponding 1-carboxylic acids Download PDF

Info

Publication number
EP0000649A1
EP0000649A1 EP78300174A EP78300174A EP0000649A1 EP 0000649 A1 EP0000649 A1 EP 0000649A1 EP 78300174 A EP78300174 A EP 78300174A EP 78300174 A EP78300174 A EP 78300174A EP 0000649 A1 EP0000649 A1 EP 0000649A1
Authority
EP
European Patent Office
Prior art keywords
pyrrole
dihydro
pyrrolo
nitrile
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP78300174A
Other languages
German (de)
French (fr)
Other versions
EP0000649B1 (en
Inventor
Albert R. Van Horn
Pasquale G. Gallegra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25225403&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP0000649(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of EP0000649A1 publication Critical patent/EP0000649A1/en
Application granted granted Critical
Publication of EP0000649B1 publication Critical patent/EP0000649B1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Definitions

  • the present invention relates to 5-substituted-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole derivatives useful as intermediates in the preparation of pharmaceutically active compounds, and to such preparative processes.
  • the present invention provides novel 5-substituted-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-nitriles of the formula:
  • the compounds of Formula (II) can, in accordance with the process hereof, be converted hydrolytically to the corresponding 5-substituted-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-carboxylic acids of the formula: wherein Y is defined as above.
  • the product compounds hereof of Formula (I) are useful as antiinflammatory agents, analgetic agents, and as smooth muscle relaxants. They can be used both prophylactically and therapeutically.
  • the new process hereof that is, the hydrolysis conversion of the compounds of Formula (II) to the compounds of Formula (I) can be carried out under a variety of acidic or basic conditions, generally those conditions employed by those skilled in the art for the conversion of nitriles to carboxylic acids.
  • hydrolysis conversion is carried out under acidic conditions it is generally preferred that it be done with a strong mineral acid, e.g., phosphoric acid, sulfuric acid, hydrochloric acid, hydrobromic acid, and the like, in the presence of water, with or without the presence of an organic acid, e.g., acetic acid, formic acid, propionic acid, and the like. If desired other organic solvents miscible with the mineral acid (and the water and the organic acid, if the latter is used) can be used.
  • a strong mineral acid e.g., phosphoric acid, sulfuric acid, hydrochloric acid, hydrobromic acid, and the like
  • an organic acid e.g., acetic acid, formic acid, propionic acid, and the like.
  • other organic solvents miscible with the mineral acid (and the water and the organic acid, if the latter is used) can be used.
  • Suitable organic solvents are methanol, ethanol, ethylene glycol, dimethylsulfoxide, dioxane, tetrahydrofuran, ethylene glycol dimethyl ether (glyme), diethylene glycol dimethyl ether (diglyme), and the like.
  • the reaction is preferably carried out under an inert atmosphere, e.g., nitrogen, argon, and the like, with nitrogen being the most preferred.
  • the reaction times and temperatures are not critical and depend, as will be apparent to those skilled in the art, on the reactants (and other ingredients of the reaction mixture) employed.
  • the reaction time can be from about one minute to about 10 hours with about five minutes to about three hours being preferred; and the reaction temperature from about 60°C to about 200°C, with about 80°C to about 120°C being preferred.
  • hydrolysis conversion is carried out under basic conditions, it is generally preferred that it be done with a strong base, preferably a mineral base, e.g., potassium hydroxide, sodium hydroxide, lithium hydroxide, and the like, in the presence of water.
  • a strong base preferably a mineral base, e.g., potassium hydroxide, sodium hydroxide, lithium hydroxide, and the like
  • water miscible organic solvents e.g., 2-methoxyethanol, methanol, ethanol, ethylene glycol, dimethylsulfoxide, and the like are used to facilitate solution of the reactants.
  • the reaction is preferably carried out under an inert atmosphere, e.g., nitrogen, argon, and the like, with nitrogen being the most preferred.
  • reaction times and temperatures are not critical and depend, as will be apparent to those skilled in the art, on the reactants (and other ingredients of the reaction mixture) employed.
  • reaction time can be from about 5 minutes to about 2 hours, with about 30 minutes to about 1 hour being preferred; and the reaction temperature from about 60°C to reflux temperature with about 70°C to reflux temperature being preferred.
  • Isolation, separation, and purification of the desired compound of Formula (I) from the reaction mixture containing it can be effected by any suitable separation or purification procedure, such as, for example, extractions, filtration, evaporation, distillation, crystallization, thin-layer chromatography, or column chromatography, high pressure liquid chromatography, and the like, or a combination of these procedures. Illustrations of suitable isolation, separation and purification procedures can be had by reference to the Examples (and Preparations) hereinbelow. However, other isolation, separation and isolation procedures, could of course, also be used.
  • temperatures are room or ambient temperature (about 20°C to about 30°C).
  • the temperature is permitted to drop to room temperature and the reaction mixture is agitated to room temperature for 15 hours, followed by the addition of 16 ml of 25% aqueous sodium hydroxide solution, agitation for 5 minutes, and the addition of 19 ml of methylene chloride and 20 ml of water.
  • the organic layer is separated and the aqueous layer is extracted with 19 ml of methylene chloride.
  • the organic portions are combined and washed with a mixture of 11 ml of saturated aqueous sodium chloride solution and'8 ml of water.
  • reaction mixture is then added to a hot (about 90°C) solution of 12.6 g of sodium cyanide in 27 ml of water, the addition being at such a rate, while at the same time distilling the solvent off, that the internal reaction flask temperature is kept at about 90°-95°C.
  • the addition is complete, the mixture is brought to reflux and heated under reflux for 15 minutes.
  • the mixture is cooled to 25°C, followed by the addition of 40 ml of water and 60 ml of methylene chloride.
  • the organic layer is separated, washed with 30 ml of a mixture of 50:50 saturated aqueous sodium chloride: water, the water layer is extracted twice with 30 ml of methylene chloride, and the combined organic layers are dried over anhydrous sodium sulfate and the solvent removed under vacuum to yield 21 g of a brown oil which upon purification on a silica gel chromatography column (using 50:50-ethyl acetate: hexane as solvent) yielded 13 g of l-hydroxyethylpyrrole-2-acetonitrile having the following analysis: Calculated: C, 63.98%; H, 6.71%; N, 18.66%. Found: C, 63.91%: H, 6.76%; N, 18.91%.
  • the thus-obtained mixture is heated to 77°C for one hour, cooled to 25°C, and 15 ml of methylene chloride is added thereto.
  • the organic salts are filtered off and washed with methylene chloride.
  • the solvent is removed from the filtrate under vacuum, leaving a residue which is taken up in a mixture of 30 ml of dilute aqueous sodium chloride solution.
  • the volume of the remaining solution is adjusted to about 2 ml by the addition of ethyl acetate, followed by cooling to 0°C, and collection by filtration to yield 0.17 g (85 % ) of 95% pure (by high pressure liquid chromatography) 5-(2-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-carboxylic acid having a melting point of 154-155°C. Additional quantities of the product can be obtained from the mother liquors by standard crystallization work-up procedures.
  • 0.45 G of the crude product is taken up in 5 ml of hot ethyl acetate, cooled to 0°C. agitated for five minutes, and following filtration, washing with 2 ml of a 2:1 ethyl acetate-hexane mixture and vacuum drying at 45°C. there is obtained 0.32 g (71% w/w) of 5-(2-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid having a melting point of 157°C-159°C. Additional quantities of the product can be obtained by standard crystallization work-up procedures.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Compounds of the formula: <CHEM> wherein Y is <CHEM> in which R is hydrogen, methyl, chloro or bromo, the R substitution being at the 3, 4 or 5 positions of the thiophene ring, R<1> is hydrogen, a lower alkyl group having 1 to 4 carbon atoms, a lower alkoxy group having from 1 to 4 carbon atoms, chloro, fluoro or bromo, the R<1> substitution being at the ortho, meta or para positions of the aroyl group, and R<2> is hydrogen or a lower alkyl group having from 1 to 4 carbon atoms. <??>These compounds are used as intermediates for the preparation of the corresponding 1-carboxylic acid compounds by hydrolysis, the latter compounds being pharmaceutically useful.

Description

  • The present invention relates to 5-substituted-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole derivatives useful as intermediates in the preparation of pharmaceutically active compounds, and to such preparative processes.
  • More particularly, the present invention provides novel 5-substituted-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-nitriles of the formula:
    Figure imgb0001
    • wherein Y is
      Figure imgb0002
    • in which R is hydrogen, methyl, chloro or bromo, the R substitution being at the 3, 4 or 5 positions of the thiophene ring,
    • R 1 is hydrogen, a lower alkyl group having 1 to 4 carbon atoms, a lower alkoxy group having from 1 to 4 carbon atoms, chloro, fluoro or bromo, the R1 substitution being at the ortho, meta or para positions of the aroyl group, and
    • R2 is hydrogen or a lower alkyl group having from 1 to 4 carbon atoms.
  • The compounds of Formula (II) can, in accordance with the process hereof, be converted hydrolytically to the corresponding 5-substituted-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-carboxylic acids of the formula:
    Figure imgb0003
    wherein Y is defined as above.
  • The conversion of the compounds of Formula (II) to the compounds of Formula (I) may be depicted schematically as follows:
    Figure imgb0004
  • The product compounds hereof of Formula (I) are useful as antiinflammatory agents, analgetic agents, and as smooth muscle relaxants. They can be used both prophylactically and therapeutically.
  • The starting compounds hereof of Formula (II) are prepared according to the preparations set forth below.
  • The new process hereof, that is, the hydrolysis conversion of the compounds of Formula (II) to the compounds of Formula (I) can be carried out under a variety of acidic or basic conditions, generally those conditions employed by those skilled in the art for the conversion of nitriles to carboxylic acids.
  • If the hydrolysis conversion is carried out under acidic conditions it is generally preferred that it be done with a strong mineral acid, e.g., phosphoric acid, sulfuric acid, hydrochloric acid, hydrobromic acid, and the like, in the presence of water, with or without the presence of an organic acid, e.g., acetic acid, formic acid, propionic acid, and the like. If desired other organic solvents miscible with the mineral acid (and the water and the organic acid, if the latter is used) can be used. Suitable organic solvents are methanol, ethanol, ethylene glycol, dimethylsulfoxide, dioxane, tetrahydrofuran, ethylene glycol dimethyl ether (glyme), diethylene glycol dimethyl ether (diglyme), and the like. The reaction is preferably carried out under an inert atmosphere, e.g., nitrogen, argon, and the like, with nitrogen being the most preferred. The reaction times and temperatures are not critical and depend, as will be apparent to those skilled in the art, on the reactants (and other ingredients of the reaction mixture) employed. Thus, the reaction time can be from about one minute to about 10 hours with about five minutes to about three hours being preferred; and the reaction temperature from about 60°C to about 200°C, with about 80°C to about 120°C being preferred.
  • If the hydrolysis conversion is carried out under basic conditions, it is generally preferred that it be done with a strong base, preferably a mineral base, e.g., potassium hydroxide, sodium hydroxide, lithium hydroxide, and the like, in the presence of water. Advantageously, water miscible organic solvents, e.g., 2-methoxyethanol, methanol, ethanol, ethylene glycol, dimethylsulfoxide, and the like are used to facilitate solution of the reactants. The reaction is preferably carried out under an inert atmosphere, e.g., nitrogen, argon, and the like, with nitrogen being the most preferred. The reaction times and temperatures are not critical and depend, as will be apparent to those skilled in the art, on the reactants (and other ingredients of the reaction mixture) employed. Thus the reaction time can be from about 5 minutes to about 2 hours, with about 30 minutes to about 1 hour being preferred; and the reaction temperature from about 60°C to reflux temperature with about 70°C to reflux temperature being preferred.
  • Isolation, separation, and purification of the desired compound of Formula (I) from the reaction mixture containing it can be effected by any suitable separation or purification procedure, such as, for example, extractions, filtration, evaporation, distillation, crystallization, thin-layer chromatography, or column chromatography, high pressure liquid chromatography, and the like, or a combination of these procedures. Illustrations of suitable isolation, separation and purification procedures can be had by reference to the Examples (and Preparations) hereinbelow. However, other isolation, separation and isolation procedures, could of course, also be used.
  • Where necessary, preparations and examples are repeated to prepare additional material for subsequent preparations and examples.
  • The following Examples (and Preparations) illustrate the invention but are not intended to limit its scope. Unless otherwise stated, temperatures are room or ambient temperature (about 20°C to about 30°C).
  • PREPARATION I
  • A. To a mixture of 8.21 g of formaldehyde solution (37% aqueous) and 8.84 g of dimethylamine hydrochloride there is added 11.5 g of N-hydroxyethyl- pyrrole (see Shun-Ichi Murahashi et al., J.S.C. Chem Comm., 1974, 931-932) over a period of about 8 minutes whilst agitating and keeping the temperature below 60°C., with cooling if necessary. The temperature is permitted to drop to room temperature and the reaction mixture is agitated to room temperature for 15 hours, followed by the addition of 16 ml of 25% aqueous sodium hydroxide solution, agitation for 5 minutes, and the addition of 19 ml of methylene chloride and 20 ml of water. The organic layer is separated and the aqueous layer is extracted with 19 ml of methylene chloride. The organic portions are combined and washed with a mixture of 11 ml of saturated aqueous sodium chloride solution and'8 ml of water. The water organic layer is dried over anhydrous sodium sulfate and the solvent is removed under vacuum to yield 17.2 g of an orange-yellow oil which, upon purification on a silica gel chromatography column (using 10% methanol in methylene chloride as solvent) yielded 12.9 g of 1-hydroxyethyl-2-[(N,N-dimethylamino)-methyl]pyrrole, having the following analysis:
    Calculated: C, 64.25%; H, 9.59%; N, 16.65%.
    Found: C, 63.39%; H, 10.14%; N, 16.46%.
  • B. To 100 ml of acetone there is added 21.5 g of 1-hydroxyethyl-2-[(N,N-dimethylamino)methyl]-pyrrole, and to this mixture at 0°C., there is added 16.4 g of dimethylsulfate, whilst keeping the temperature below 2°C during the addition. The temperature is then permitted to rise to room temperature and the reaction mixture agitated at room temperature for one hour. The thus-obtained reaction mixture is then added to a hot (about 90°C) solution of 12.6 g of sodium cyanide in 27 ml of water, the addition being at such a rate, while at the same time distilling the solvent off, that the internal reaction flask temperature is kept at about 90°-95°C. When the addition is complete, the mixture is brought to reflux and heated under reflux for 15 minutes. The mixture is cooled to 25°C, followed by the addition of 40 ml of water and 60 ml of methylene chloride. The organic layer is separated, washed with 30 ml of a mixture of 50:50 saturated aqueous sodium chloride: water, the water layer is extracted twice with 30 ml of methylene chloride, and the combined organic layers are dried over anhydrous sodium sulfate and the solvent removed under vacuum to yield 21 g of a brown oil which upon purification on a silica gel chromatography column (using 50:50-ethyl acetate: hexane as solvent) yielded 13 g of l-hydroxyethylpyrrole-2-acetonitrile having the following analysis:
    Calculated: C, 63.98%; H, 6.71%; N, 18.66%.
    Found: C, 63.91%: H, 6.76%; N, 18.91%.
  • C. 1.6 G of l-hydroxyethylpyrrole-2-acetonitrile is charged to a mixture of 12 ml of methylene chloride and 1.3 g of triethylamine, the flask being purged with nitrogen and the contents thereof being cooled to -10°C. 1.34 G of methanesulfonyl chloride is then added, whilst maintaining the temperature below 0°C, and the reaction mixture is agitated at 0°C, for 15 minutes. To the reaction mixture is added 10 ml of a mixture of 50:50-saturated aqueous sodium chloride solution:water, followed by extracting four times with 15 ml portions of methylene chloride and washing with dilute aqueous sodium chloride solution, drying over anhydrous sodium sulfate and removing the solvent under vacuum to yield 2.52 g of crude 1-(2'-methanesulfonyl- ethane)-pyrrole-2-acetonitrile which is added to a mixture of 35 ml of acetonitrile and 3.76 g sodium iodide. The thus-obtained mixture is heated to 77°C for one hour, cooled to 25°C, and 15 ml of methylene chloride is added thereto. The organic salts are filtered off and washed with methylene chloride. The solvent is removed from the filtrate under vacuum, leaving a residue which is taken up in a mixture of 30 ml of dilute aqueous sodium chloride solution. The organic layer obtained is dried over anhydrous sodium sulfate and the solvent removed under vacuum to yield 2.85 g of crude 1-(2-iodoethane)-pyrrole-2-acetonitrile, 2.7 g of which, dissolved in 10 ml of dimethylformamide, is added slowly, keeping the temperature below 15°C, to a suspension of 0.24 g of sodium hydride (obtained from 0.48 g of a 50% oil dispersion) in 10 ml of dimethylformamide. The reaction slurry, under a nitrogen atmosphere, is agitated for one hour at 20°C, followed by the addition of 35 ml of water and. extracted with five 20 ml portions of diethyl ether. The organic extracts are combined and dried over sodium sulfate, followed by removal of the solvent at atmospheric pressure to yield 1.4 g of a brown oil which upon purification on a silica gel chromotography column (using 3:1 hexane:ethyl acetate as solvent) yielded 1 g of 1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile having a melting point of 44°-45°C (crystallized from ethanol) and the following analysis:
    Calculated: C, 72.70%; H, 6.10%; N, 21.20%.
    Found: C, 72.72%; H, 6.25%; N, 21.17%.
  • PREPARATION 2
  • 250 G of 2-theonyl chloride [prepared according to the method of L.D. Jones and C.D. Hurd, J. Am. Chem. Soc., 43, 2444 (1921)] is charged to 1500 ml of tetrahydrofuran. The mixture is cooled to 0°C, and 1217 ml of 40% aqueous dimethylamine solution is added whilst keeping the temperature below 20°C. The reaction mixture is stirred for 15 minutes followed by removal of the tetrahydrofuran under vacuum, extraction of the aqueous solution with two portions of 1500 ml methylene chloride, drying over anhydrous sodium sulfate and removal of the solvent under vacuum. The residue remaining is distilled at 146°C, at 9 mm Hg pressure to yield 227.3 g of N,N-dimethyl-2-thienylcarboxyamide having a melting point of 40°-41.5°C.
  • In like manner substituting a stoichiometric equivalent amount of
    • benzoyl chloride,
    • o-toluoyl chloride,
    • .m-toluoyl chloride,
    • p-toluoyl chloride,
    • p-methoxybenzoyl chloride,
    • p-ethoxybenzoyl chloride,
    • o-chlorobenzoyl chloride,
    • m-chlorobenzoyl chloride,
    • p-chlorobenzoyl chloride,
    • o-fluorobenzoyl chloride,
    • m-fluorobenzoyl chloride,
    • p-fluorobenzoyl chloride,
    • 3-chloro-2-thenoyl chloride,
    • 4-chloro-2-thenoyl chloride,
    • 5-chloro-2-thenoyl chloride,
    • 3-bromo-2-thenoyl chloride,
    • 4-bromo-2-thenoyl, chloride,
    • 5-bromo-2-theonyl chloride,
    • 3-methyl-2-theonyl chloride,
    • 4-methyl-2-theonyl chloride,
    • 5-methyl-2-theonyl chloride,
    • 2-pyrroyl chloride,
    • N-methyl-2-pyrroyl chloride, and
    • N-n-butyl-2-pyrroyl chloride,
    • for 2-theonyl chloride, there are obtained
    • N,N-dimethyl-2-benzoylcarboxamide,
    • N,N-dimethyl-2-o-toluoylcarboxamide,
    • N,N-dimethyl-2-m-toluoylcarboxamide,
    • N,N-dimethyl-2-p-toluoylcarboxamide,
    • N,N-dimethyl-2-p-methoxybenzoylcarboxamide,
    • N,N-dimethyl-2-p-ethoxybenzoylcarboxamide,
    • N,N-dimethyl-2-o-chlorobenzoylcarboxamide,
    • N,N-dimethyl-2-m-chlorobenzoylcarboxamide,
    • N,N-dimethyl-2-p-chlorobenzoylcarboxamide,
    • N,N-dimethyl-2-o-fluorobenzoylcarboxamide,
    • N,N-dimethyl-2-m-fluorobenzoylcarboxamide,
    • N,N-dimethyl-2-p-fluorobenzoylcarboxamide,
    • N,N-dimethyl-2-(3-chloro-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(4-chloro-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(5-chloro-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(3-bromo-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(4-bromo-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(5-bromo-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(3-methyl-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(4-methyl-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(5-methyl-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(2-pyrroyl)carboxamide,
    • N,N-dimethyl-2-(N-methyl-2-pyrroyl)carboxamide,
    • and N,N-dimethyl-2-(N-n-butyl-2-pyrroyl)-carboxamide respectively,
    PREPARATION 3
  • 1.77 G of N,N-dimethyl-2-thienylcarboxamide is charged to a mixture of 12.2 ml of 1,2-dichloroethane and 1.74 g of phosphorus oxychloride. The mixture is purged with nitrogen and heted to reflux for 1 1/2 hours. After cooling to 25°C a solution of 0.95 g of 1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile in 4.4 ml of 1,2-dichlorethane is added and the thus-obtained solution is heated at reflux for 10 hours, after which time it is cooled to 25°C. To the cooled solution there is added a solution of 5.12 g of sodium acetate in 48 ml of water followed by heating to reflux for one hour, under vigorous agitation, cooling to room temperaturee and Separation of the organic layer. The water layer is extracted twice with 20 ml portions of methylene chloride and each organic layer is washed with 20 ml of dilute aqueous sodium carbonate solution and then with 20 ml of dilute aqueous sodium chloride solution. The combined organic solutions are dried over anhydrous sodium sulfate and the solvent is removed under vacuum to yield 2.4 g of a brown oil which upon purification on a silica gel chromotography column (using 2.5:l-hexane acetate as solvent) yielded 1.45 g of 5-(2-thenoyl)-l,2-dihydro-3H-pyrrolo[1,2-a]- pyrrole-1-nitrile having a melting point of 106°-107.5°C, (crystallized from ethanol) and the following analysis:
    • Calculated: C, 64.44%; H, 4.16%; N, 11.56%; S, 13.24%.
    • found: C, 64.54%; H, 4.10%, N, 11.48%; S, 13.46%.
  • In like manner substituting a stoichiometric equivalent amount of
    • N,N-dimethyl-2-benzoylcarboxamide,
    • N,N-dimethyl-2-o-toluoylcarboxamide,
    • N,N-dimethyl-2-m-toluoylcarboxamide,
    • N,N-dimethyl-2-p-toluoylcarboxamide,
    • N,N-dimethyl-2-p-methoxybenzoylcarboxamide,
    • N,N-dimethyl-2-p-ethoxybenzoylcarboxamide,
    • N,N-dimethyl-2-o-chlorobenzoylcarboxamide,
    • N,N-dimethyl-2-m-chlorobenzoylcarboxamide,
    • N,N-dimethyl-2-p-chlorobenzoylcarboxamide,
    • N,N-dimethyl-2-o-fluorobenzoylcarboxamide,
    • N,N-dimethyl-2-m-fluorobenzoylcarboxamide,
    • N,N-dimethyl-2-p-fluorobenzoylcarboxamide,
    • N,N-dimethyl-2-(3-chloro-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(4-chloro-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(5-chloro-2-thienyl)carbbxamide,
    • N,N-dimethyl-2-(3-bromo-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(4-bromo-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(5-bromo-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(3-methyl-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(4-methyl-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(5-methyl-2-thienyl)carboxamide,
    • N,N-dimethyl-2-(2-pyrroyl)carboxamide,
    • N,N-dimethyl-2-(N-methyl-2-pyrroyl)carboxamide,
    • N,N-dimethyl-2-(N-n-butyl-2-pyrroyl)carboxamide,
    • for N,N-dimethyl-2-thienylcarboxamide, there is obtained
    • 5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1- nitrile,
    • 5-o-toluoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitrile,
    • 5-m-toluoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitrile,
    • 5-p-toluoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole- nitrile,
    • 5-p-methoxybenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrroloe-l-nitrile,
    • 5-p-ethoxybenzoyl-1,2-dihdyro-3H-pyrrolo[1,2-a]-pyrrole-1-nitrile,
    • 5-o-chlorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-nitrile,
    • 5-m-chlorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-nitrile,
    • 5-p-chlorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-nitrile,
    • 5-o-fluorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-nitrile,
    • 5-m-fluorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-nitrile,
    • 5-p-fluorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-nitrile,
    • 5-(3-cbloro-2-theonyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile,
    • 5-(4-chloro-2-theonyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrale-1-nitrile,
    • . 5-(5-chloro-2-theonyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile,
    • 5-(3-bromo-2-theonyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile,
    • 5-(4-bromo-2-theonyl)-1,2-dihydro-3H-pyrrolo-[l,2-a]pyrrole-l-nitrile,
    • 5-(5-bromo-2-theonyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile,
    • 5-(3-methyl-2-theonyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile,
    • 5-(4-methyl-2-theonyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile,
    • 5-(5-methyl-2-theonyl)-1,2-dihydro-3H-pyrrolo-[l,2-a]pyrrole-l-nitrile,
    • 5-(2-pyrroyl)-1,2-dihydro-3H-pyrrolo[l,2-a]-pyrrolo-l-nitrile,
    • 5-(N-methyl-2-pyrroyl)-1,2-dihydro-3H-pyrrolo-[l,2-a]pyrrole-l-nitrile, and
    • 5-(N-n-butyl-2-pyrroyl)-l,2-dihydro-3H-pyrrolo-[-l,2-a]pyrrole-l-nitrile, respectively.
    EXAMPLE 1
  • To 3.5 g of concentrated hydrochloric acid (37% aqueous) there is added, at room temperature, 0.3 g of 5-(2-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-nitrile. The reaction mixture is purged with nitrogen and warmed to 100°C. The reaction mixture is agitated for seven minutes, while maintaining it under a nitrogen atmosphere, cooled to room temperature, and 10 ml of cool water (at 4°C) is added thereto. The reaction mixture is then extracted with two 5 ml portions of ethyl acetate. The ethyl acetate extracts are combined, dried over anhydrous sodium sulfate, followed by complete evaporation of the solvent to yield 0.32 g (102%) of a crude product (93% pure as measured by high pressure liquid chromatography) containing 5-(2-theonyl)-1,2-dihydro-3H-pyrrolo[1,2]pyrrole-1-carboxylic acid.
  • 0.3 G. of the thus-obtained crude product is dissolved in 3 ml of hot ethyl acetate, cooled to 0°C and collected by filtration to yield 0.2 g. (66.6%) of 5-(2-theonyly-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-carboxylic acid having a melting point of 154-155°C. Additional quantities of the product can be obtained for the mother.liquor.
  • The 0.2 g of 5-(2-thenoyl)-l,2-dihydro-3H-pyrrolo[l,2-a]pyrrole-l-carboxylic acid obtained above is taken up in 3 ml of ethyl acetate and 1 ml of methanol and 0.2 g of decolorizing charcoal is added. The mixture is warmed to 50°C., followed by removal of the decolorizing charcoal by filtration and the methanol by distillation. The volume of the remaining solution is adjusted to about 2 ml by the addition of ethyl acetate, followed by cooling to 0°C, and collection by filtration to yield 0.17 g (85%) of 95% pure (by high pressure liquid chromatography) 5-(2-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-carboxylic acid having a melting point of 154-155°C. Additional quantities of the product can be obtained from the mother liquors by standard crystallization work-up procedures.
  • Similarly, replacement of the concentrated hydrochloric acid (37% aqueous) by a stoichiometric equivalent amount of sulfuric acid (40% aqueous) is productive of 5-(2-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-carboxylic acid.
  • EXAMPLE 2
  • To 3.5 g of 60% aqueous sulfuric acid there is added 0.5 g of 5-(2-thenoyl)-l,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile. The reaction mixture is purged with nitrogen and warmed to 100°C. The reaction mixture is agitated for twelve minutes, whilst maintaining it under a nitrogen atmosphere, and 10 ml of cold water (at 4°C.) is added thereto. The reaction mixture is then extracted with two 5 ml portions of ethyl acetate. The ethyl acetate extracts are combined, dried over anhydrous sodium sulfate and concentrated to dryness to yield 0.5 g (92.7%) of a crude product (56% pure as measured by high pressure liquid chromatography) containing 5-(2-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid.
  • 0.4 g of the thus-obtained crude product is dissolved in 4 ml of methanol and 4 ml of water is added thereto. The mixture is agitated, followed by filtration. The solid material thus-obtained is taken up in 5 ml of ethyl acetate and 1 ml of methanol and 0.5 g of decolorizing charcoal is added thereto. The mixture is warmed to 50°C., the decolorizing charcoal is filtered off and the methanol is removed. The volume is then adjusted to about 2 ml by the addition of ethyl acetate, followed by cooling to 0°C. and filtration to yield 0.2 g (50%) 5-(2-thenoyl)-l,2-di- hydro-3H-pyrrolo[l,2-a]pyrrole-l-carboxylic acid having a melting point of 147°-148°C. The melting point remained the same following a second crystallization from ethyl acetate and high pressure liquid chromotography indicated a purity of 79.8%.
  • EXAMPLE 3
  • To a mixture of 8 ml of glacial acetic acid and 8 ml of 85% phosphoric acid there is added 1.6 g of 5-(2-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1- nitrile. The reaction mixture is purged with nitrogen and maintained, under a nitrogen atmosphere, at 110°C-115°C. for two hours and twenty minutes. The reaction mixture is cooled and added to 50 ml of a mixture of 70% aqueous saturated sodium chloride solution-30% water. The material which precipitates is extracted with 10 ml of ethyl acetate and the extract is dried over anhydrous sodium sulfate and concentrated to remove nearly all the solvent, followed by the addition of 20 ml of hexane, filtration and vacuum drying at 45°C. to yield 1.66 g (96.3%) of a crude product (79% pure as measured by high pressure liquid chromatography) containing 5-(2-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid.
  • 1.4 G of the thus-obtained crude product is taken up in 15 ml of methanol and 0.5 g of decolorizing charcoal is added thereto, followed by agitation of the mixture for 15 minutes, filtration to remove the charcoal, and concentration to a volume of 5 ml., to which 5 ml of water is added. The aqueous mixture is agitated for ten minutes, followed by filtration to yield 1.1 g (78.6%) of product containing 5-(2- thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-carboxylic acid.
  • 1.0 G of the product, obtained immediately above, is taken up in 6 ml of hot ethyl acetate and the mixture is cooled to 0°C., agitated for 15 minutes, followed by filtration and washing with 2 ml of cold (0°C.) ethyl acetate to yield 0.6 g (60%) of 5-(2-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-carboxylic acid having a melting point of 158°C-l59°C. Additional quantities of product can be obtained from the ethyl acetate liquors by standard crystallization work-up procedures.
  • EXAMPLE 4
  • To 7.8 ml of 2-methoxyethanol there is added 0.8 g of 5-(2-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-al pyrrole-l-nitrile. Following purgation with nitrogen, 1.6 ml of 20% aqueous potassium hydroxide solution is added and the reaction mixture, under a nitrogen atmosphere, is refluxed for a period of 48 minutes. The reaction solution is cooled to 20°C., 10 ml of water is added thereto, followed by washing with 20 ml of methylene chloride. To the aqueous portion, following extraction, there is added concentrated hydrochloric acid to attain a pH of about 3, and the material which precipitates is extracted with 20 ml of ethyl acetate, dried over anhydrous sodium sulfate and concentrated to dryness to yield 0.776 g (90%) of crude product containing 5-(2-thenoyl)-l,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid.
  • 0.45 G of the crude product is taken up in 5 ml of hot ethyl acetate, cooled to 0°C. agitated for five minutes, and following filtration, washing with 2 ml of a 2:1 ethyl acetate-hexane mixture and vacuum drying at 45°C. there is obtained 0.32 g (71% w/w) of 5-(2-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid having a melting point of 157°C-159°C. Additional quantities of the product can be obtained by standard crystallization work-up procedures.
  • Similarly replacement of the potassium hydroxide by a stoichiometric equivalent amount of sodium hydroxide, or lithium hydroxide, is productive of 5-(2-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid.
  • EXAMPLE 5
  • Following the procedures set forth in Examples 1, 2, 3, and 4 and substituting a stoichiometric equivalent amount of
    • 5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1- nitrile,
    • 5-o-toluoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitrile,
    • 5-m-toluoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitrile,
    • 5-p-toluoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitrile,
    • 5-p-methoxybenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-nitrile,
    • 5-p-ethoxybenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-nitrile,
    • 5-o-chlorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-nitrile,
    • 5-m-chlorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a] pyrrole-l-nitrile,
    • 5-p-chlorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a] pyrrole-l-nitrile,
    • 5-o-fluorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a] pyrrole-l-nitrile,
    • 5-m-fluorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a] pyrrole-1-nitrile,
    • 5-p-fluorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a] pyrrole-l-nitrile,
    • 5-(3-chloro-2-theonyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile.
    • 5-(4-chloro-2-theonyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile,
    • 5-(5-chloro-2-theonyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile.
    • 5-(3-bromo-2-theonyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile,
    • 5-(4-bromo-2-theonyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile,
    • 5-(5-bromo-2-theonyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile,
    • 5-(3-methyl-2-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile,
    • 5-(4-methyl-2-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile,
    • 5-(5-methyl-2-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile,
    • 5-(2-pyrroyl)-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-nitrile,
    • 5-(N-methyl-2-pyrroyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-nitrile,
    • 5-(N-n-butyl-2-pyrroyl)-l,2-dihydro-3H-pyrrolo-[1,2-a]pyrole-1-nitrile, for
    • 5-(2-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-nitrile, there are obtained
    • 5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid, which has a m.p. of 160-161°C.,
    • 5-o-toluoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid, which is an oil,
    • 5-m-toluoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid,
    • 5-p-toluoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid, which has a m.p. of 182-183°C.,
    • 5-p-methoxybenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-carboxylic acid, which has a m.p. of 187-187.5°C.,
    • 5-p-ethoxybenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-carboxylic acid, which has a m.p. of 169.5-170°C.,
    • 5-o-chlorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-carboxylic acid,
    • 5-m-chlorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-carboxylic acid, which has a m.p. of 180-181°C.,
    • 5-p-chlorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-carboxylic acid, which has a m.p. of 201.5-202.5°C.,
    • 5-o-fluorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-carboxylic acid,
    • 5-m-fluorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-carboxylic acid,
    • 5-p-fluorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-carboxylic acid, which has a m.p. of 179.5-180.5°C.,
    • 5-(3-chloro-2-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a] pyrrole-l-carboxylic acid,
    • 5-(4-chloro-2-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a] pyrrole-l-carboxylic acid,
    • 5-(5-chloro-2-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a] pyrrole-1-carboxylic acid,
    • 5-(3-bromo-2-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a] pyrrole-1-carboxylic acid,
    • 5-(4-bromo-2-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a] pyrrole-l-carboxylic acid,
    • 5-(5-bromo-2-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a] pyrrole-1-carboxylic acid,
    • 5-(3-methyl-2-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a] pyrrole-l-carboxylic acid,
    • 5-(4-methyl-2-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a] pyrrole-1-carboxylic acid,
    • 5-(5-methyl-2-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a] pyrrole-l-carboxylic acid,
    • 5-(2-pyrroyl)-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-l-carboxylic acid, having a m.p. of 217-218°C.,
    • 5-(N-methyl-2-pyrroyl)-1,2-dihydro-3H-pyrrolo-[1,2-a] pyrrole-1-carboxylic acid, having a m.p. of 161-161.5°C., and
    • 5-(N-n-butyl-2-pyrroyl)-1,2-dihydro-3H-pyrrolo-[1,2-a] pyrrole-l-carboxylic acid, respectively.

Claims (11)

1. A compound of the formula:
Figure imgb0005
wherein Y is
Figure imgb0006
in which R is hydrogen, methyl, chloro or bromo, the R substitution being at the 3,4 or 5 positions of the thiophene ring,
R 1 is hydrogen, a lower alkyl group having 1 to 4 carbons atoms, a lower alkoxy group having from 1 to 4 carbon atoms, chloro, fluoro or bromo, the R1 substitution being at the ortho, meta or para positions of the aroyl group, and
R2 is hydrogen or a lower alkyl group having from 1 to 4 carbon atoms.
2. According to claim 1, the compound 5-(2-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitrile.
3. According to claim 1, the compound 5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitrile.
4. According to claim 1, the compound 5-m-chlorobenzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1- nitrile.
5. A process for the production of a compound of the formula:
Figure imgb0007
wherein Y (and R, R1 and R2) are defined as in claim 1, characterised in that it comprises hydrolysis of the nitrile group of a compound of claim 1.
6. The process according to claim 5 in which the hydrolysis is conducted under acidic conditions.
7. The process according to claim 5 in which the hydrolysis is conducted under basic conditions.
8. The process according to claims 5, 6 or 7 for the production of 5-(2-thenoyl)-1,2-dihydro-3H-pyrrolo [1,2-a]pyrrole-1-carboxylic acid.
9. The process according to claims 5, 6 or 7 for the production of 5-benzoyl-1,2-dihydro-3H-pyrrolofl,2-a] pyrrole-1-carboxylic acid.
10. The process according to claims 5, 6 or 7 for the production of 5-m-chlorobenzoyl-1,2-dihydro-3H-pyrrolo [1,2-a]pyrrole-1-carboxylic acid.
MEWBURN ELLIS & CO. Chartered Patent Agents. 70/72 Chancery Lane, London, WC2A 1AD. Agents for the Applicants.
EP78300174A 1977-07-25 1978-07-20 5-substituted-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrole-1-carbonitriles and process for their conversion to the corresponding 1-carboxylic acids Expired EP0000649B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81837777A 1977-07-25 1977-07-25
US818377 1977-07-25

Publications (2)

Publication Number Publication Date
EP0000649A1 true EP0000649A1 (en) 1979-02-07
EP0000649B1 EP0000649B1 (en) 1981-03-25

Family

ID=25225403

Family Applications (1)

Application Number Title Priority Date Filing Date
EP78300174A Expired EP0000649B1 (en) 1977-07-25 1978-07-20 5-substituted-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrole-1-carbonitriles and process for their conversion to the corresponding 1-carboxylic acids

Country Status (27)

Country Link
US (1) US4140698A (en)
EP (1) EP0000649B1 (en)
JP (1) JPS5424889A (en)
AT (1) AT364843B (en)
AU (1) AU515352B2 (en)
CA (1) CA1111431A (en)
CS (1) CS201015B2 (en)
DD (1) DD137229A5 (en)
DE (1) DE2860560D1 (en)
DK (1) DK146720C (en)
ES (1) ES472002A1 (en)
FI (1) FI64597C (en)
GR (1) GR63733B (en)
HK (1) HK17186A (en)
HU (1) HU178354B (en)
IE (1) IE47138B1 (en)
IL (1) IL55181A (en)
IT (1) IT1160443B (en)
MY (1) MY8800142A (en)
NO (2) NO166863C (en)
NZ (1) NZ187924A (en)
PL (1) PL111419B1 (en)
PT (1) PT68328A (en)
SG (1) SG31884G (en)
SU (1) SU1138029A3 (en)
YU (1) YU40717B (en)
ZA (1) ZA784216B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983001382A1 (en) * 1981-10-13 1983-04-28 Mroszczak, Edward Gastrointestinal sparing thioester pro-drugs
EP0034481B1 (en) * 1980-02-14 1984-05-30 Grigg, Ronald Ernest 2-methyl-5-thiazole-methylamine and carboxamide derivatives
US4548948A (en) * 1983-02-19 1985-10-22 Beecham Group P.L.C. Anti-inflammatory and analgesic benzothiophene and benzafuran derivatives, compositions, and method of use therefor
WO2000002855A2 (en) * 1998-07-10 2000-01-20 Mallinckrodt Inc. Synthesis of compounds useful in the manufacture of ketorolac

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232038A (en) * 1979-08-31 1980-11-04 Syntex (U.S.A.) Inc. 5-Alkylsulfinylbenzoyl- and 5-alkylsulfonylbenzoyl-1,2-dihydro-3H-pyrrolo[1,]pyrrole-1-carboxylic acids
US4344943A (en) * 1980-06-09 1982-08-17 Syntex (U.S.A.) Inc. 6-Chloro- or 6-bromo-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-carboxylic acids and derivatives thereof
US4353829A (en) * 1980-11-21 1982-10-12 Syntex (U.S.A.) Inc. Process for 5-aroylation of 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic esters
US4397862A (en) * 1981-10-13 1983-08-09 Syntex (U.S.A.) Inc. Gastrointestinal sparing thioester drugs
US4457941A (en) * 1982-03-22 1984-07-03 Syntex (U.S.A.) Inc. Use of pyrrolo-pyrrole in treating microvascular diseases associated with diabetes
US4454151A (en) * 1982-03-22 1984-06-12 Syntex (U.S.A.) Inc. Use of pyrrolo pyrroles in treatment of ophthalmic diseases
US4874871A (en) * 1987-03-25 1989-10-17 Syntex (U.S.A.) Inc. Process for preparing (+)-2,3-Dihydro-1H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid and related compounds
JP2649168B2 (en) * 1988-02-25 1997-09-03 久光製薬株式会社 Novel 5,6-diphenyl-1,2-dihydro-3H-pyrrolo [1,2-a] pyrrole-1-carboxylic acid derivatives
EP0707465A4 (en) * 1993-07-08 1997-04-16 Cygnus Therapeutic Systems Monolithic matrix transdermal delivery system
US5621115A (en) * 1996-02-21 1997-04-15 Ohmeda Pharmaceutical Products Division Inc. Methods for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo-[1,2-A]pyrrole-1-carboxylic acids
US6191285B1 (en) 1997-07-03 2001-02-20 Abbott Laboratories Process for the preparation of ketorolac tromethamine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7707651A (en) * 1976-07-14 1978-01-17 Syntex Inc PROCEDURE FOR PREPARING PYRROOL-1-CARBON ACIDS.
NL7707652A (en) * 1976-07-14 1978-01-17 Syntex Inc PROCEDURE FOR PREPARING PYRROOL-1-CARBON ACIDS.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087539A (en) * 1976-07-14 1978-05-02 Syntex (U.S.A.) Inc. 5-(2-Furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4097579A (en) * 1977-03-31 1978-06-27 Syntex (U.S.A.) Inc. 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7707651A (en) * 1976-07-14 1978-01-17 Syntex Inc PROCEDURE FOR PREPARING PYRROOL-1-CARBON ACIDS.
NL7707652A (en) * 1976-07-14 1978-01-17 Syntex Inc PROCEDURE FOR PREPARING PYRROOL-1-CARBON ACIDS.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF ORGANIC CHEMISTRY, 39, (1974), page 731 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0034481B1 (en) * 1980-02-14 1984-05-30 Grigg, Ronald Ernest 2-methyl-5-thiazole-methylamine and carboxamide derivatives
WO1983001382A1 (en) * 1981-10-13 1983-04-28 Mroszczak, Edward Gastrointestinal sparing thioester pro-drugs
US4548948A (en) * 1983-02-19 1985-10-22 Beecham Group P.L.C. Anti-inflammatory and analgesic benzothiophene and benzafuran derivatives, compositions, and method of use therefor
WO2000002855A2 (en) * 1998-07-10 2000-01-20 Mallinckrodt Inc. Synthesis of compounds useful in the manufacture of ketorolac
WO2000002855A3 (en) * 1998-07-10 2000-02-24 Mallinckrodt Inc Synthesis of compounds useful in the manufacture of ketorolac
US6376681B1 (en) * 1998-07-10 2002-04-23 Mallinckodt Inc. Synthesis of compounds useful in the manufacture of ketorolac
US6559319B2 (en) * 1998-07-10 2003-05-06 Mallinckrodt Inc. Synthesis of compounds useful in the manufacture of ketorolac

Also Published As

Publication number Publication date
IT1160443B (en) 1987-03-11
SU1138029A3 (en) 1985-01-30
DK146720B (en) 1983-12-12
US4140698A (en) 1979-02-20
CS201015B2 (en) 1980-10-31
CA1111431A (en) 1981-10-27
NO155244C (en) 1987-03-04
IT7868765A0 (en) 1978-07-24
SG31884G (en) 1985-09-13
NO155244B (en) 1986-11-24
HU178354B (en) 1982-04-28
DK146720C (en) 1984-08-20
NO166863B (en) 1991-06-03
FI64597C (en) 1983-12-12
AT364843B (en) 1981-11-25
PT68328A (en) 1978-08-01
NO782545L (en) 1979-01-26
FI64597B (en) 1983-08-31
GR63733B (en) 1979-12-04
FI782307A (en) 1979-01-26
ES472002A1 (en) 1984-07-16
IE47138B1 (en) 1983-12-28
AU3826978A (en) 1980-01-31
ATA528978A (en) 1981-04-15
PL111419B1 (en) 1980-08-30
DD137229A5 (en) 1979-08-22
IL55181A0 (en) 1978-09-29
YU174178A (en) 1983-01-21
MY8800142A (en) 1988-12-31
AU515352B2 (en) 1981-04-02
HK17186A (en) 1986-03-21
JPS6337793B2 (en) 1988-07-27
NO166863C (en) 1991-09-11
JPS5424889A (en) 1979-02-24
PL208576A1 (en) 1979-05-07
DK325078A (en) 1979-01-26
IL55181A (en) 1981-12-31
DE2860560D1 (en) 1981-04-16
IE781473L (en) 1979-01-25
NO851935L (en) 1979-01-26
ZA784216B (en) 1980-02-27
NZ187924A (en) 1980-03-05
EP0000649B1 (en) 1981-03-25
YU40717B (en) 1986-04-30

Similar Documents

Publication Publication Date Title
EP0428437B1 (en) 1,2-Benzisoxazole derivatives, process for their preparation and pharmaceutical compositions containing them
EP0000649B1 (en) 5-substituted-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrole-1-carbonitriles and process for their conversion to the corresponding 1-carboxylic acids
DE60012044T2 (en) Imidazopyridine derivatives as ligands for GABA receptors
DE60207416T2 (en) IMIDAZOTRIAZINE DERIVATIVES AS GABA RECEPTOR LIGANDS
EP0001534B1 (en) Pyrrole derivatives, method for their preparation and their therapeutical use
EP0253711B1 (en) 1H,3H-pyrrolo[1,2-c]thiazole derivatives, their preparation and pharmaceutical compositions containing them
CH619463A5 (en)
EP0934319A1 (en) 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS
EP0139584B1 (en) Imidazoline derivatives, their preparation and therapeutical use
EP0008249A2 (en) Fluorene and fluoranthene derivatives, process for their preparation and their therapeutic application
GB2204037A (en) N-substituted 4-hydroxypyridine-3-carboxamides
CH645370A5 (en) PYRANONE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
JPS6031823B2 (en) Method for producing carbazole derivatives
EP1023283B1 (en) Synthesis of 3-carbomethoxy-4,5-dimethylthiophene
KR810001173B1 (en) Process for preparing 5-substituted-1,2-dihydro-3h-pyrrolo(1,2-alpha)-pyrrole-1-carboxylic acid from their corresponding novel nitriles
Boyer et al. The synthesis of 1, 3‐dihydro‐1‐[1‐[(4‐methyl‐4H‐6H‐pyrrolo [1, 2‐a][4, 1] benzoxazepin‐4‐yl) methyl]‐4‐piperidinyl]‐2H‐benzimidazol‐2‐one (1: 1) maleate (CGS 9343 B, potent calmodulin inhibitor)
JP2002533334A (en) Process for preparing tricyclic compounds with antihistamine activity
WO1990015060A1 (en) 4,5,6,11-TETRAHYDROBENZO[6,7]CYCLOOCTA[1,2-b]THIOPHEN-6,11-IMINES AND 6,11-DIHYDROBENZO[6,7]CYCLOOCTA[1,2-b]THIOPHEN-6,11-IMINES
EP0226320B1 (en) Imidazolyl thieno-benzothiepin derivatives and processes for the preparation thereof
CA1085412A (en) Thienothienylcarbonylphenyl-alkanoic acids and their derivatives; their preparation thereof and compositions that contain them
CA1127652A (en) Process for producing dibenzothiepin propionamide derivatives
CA2010713A1 (en) 1-arylsulfonyl pyrrolidine-2-thione ou 1-arylsulfonyl piperidine-2-thione derivatives, process for their preparation, use as medicament and compositions containing the same
BE895586A (en) NOVEL INDOLINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
EP0605295A1 (en) Derivatives of 2-thienylimidazo 2,1-b benzothiazole-3-acetic acid, their preparation and their therapeutical use
Jackson 3-(p-Methoxyphenoxy)-2, 6-dinitrobenzaldehyde and Two of Its Derivatives

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): BE CH DE FR GB LU NL SE

17P Request for examination filed
GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Designated state(s): BE CH DE FR GB LU NL SE

REF Corresponds to:

Ref document number: 2860560

Country of ref document: DE

Date of ref document: 19810416

EPTA Lu: last paid annual fee
EAL Se: european patent in force in sweden

Ref document number: 78300174.6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19970617

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 19970620

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19970625

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19970711

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19970729

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19970808

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 19970911

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19971014

Year of fee payment: 20

BE20 Be: patent expired

Free format text: 980720 *SYNTEX (U.S.A.) INC.

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 19980719

Ref country code: CH

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 19980719

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 19980720

Ref country code: LU

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 19980720

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980721

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Effective date: 19980719

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

NLV7 Nl: ceased due to reaching the maximum lifetime of a patent

Effective date: 19980720

EUG Se: european patent has lapsed

Ref document number: 78300174.6

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT